CVS Health denies coverage for breakthrough HIV drug, committing 'clear violation' of ACA
CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory factors."
August 22, 2025
By continuing to use our site, you agree to our Privacy Policy and Terms of Use.
CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory factors."
Yeztugo, generic name lenacapavir, has been approved after nearly eliminating the spread of HIV among trial patients.
The availability of a generic version likely means a lower cost of PrEP.

Youth can now benefit from the HIV prevention treatment.
The Food and Drug Administration on Wednesday approved Atripla, a combination pill containing three anti-HIV drugs that's taken just once daily. The pill will be the simplest antiretroviral regimen ever available in the United States.